SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Krebs Biochemicals & Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524518

INE268B01013

-75.4893276

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KREBSBIO

142.24

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	43.31	50.42	52.13	59.70	53.70	33.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	43.31	50.42	52.13	59.70	53.70	33.41
Other Income	0.71	0.45	0.62	1.16	0.62	0.37
Stock Adjustments	-3.03	-1.07	-5.87	5.54	-0.32	3.32
Total Income	40.99	49.80	46.88	66.40	54.00	37.10
EXPENDITURE :
Raw Materials	2.53	5.52	19.81	46.18	25.62	19.18
Power & Fuel Cost	18.52	22.01	14.80	22.23	15.91	10.28
Employee Cost	16.30	16.17	15.54	14.96	15.30	14.56
Other Manufacturing Expenses	12.59	9.75	7.17	9.64	10.48	6.95
Selling & Administrative Expenses	5.24	4.50	4.57	6.11	3.39	4.01
Miscellaneous Expenses	0.13	0.11	0.17	0.11	0.24	0.31
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	55.32	58.08	62.05	99.24	70.95	55.29
Operating Profit	-14.32	-8.27	-15.16	-32.84	-16.95	-18.19
Interest	5.91	4.69	2.97	5.39	6.28	6.00
Gross Profit	-20.23	-12.96	-18.13	-38.23	-23.23	-24.19
Depreciation	6.69	6.77	6.56	6.30	5.12	4.68
Profit Before Tax	-26.92	-19.73	-24.69	-44.53	-28.35	-28.87
Tax	0.02	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	-26.94	-19.73	-24.69	-44.53	-28.36	-28.87
Extraordinary Items	0.12	0.00	0.00	0.00	0.00	0.01
Adjusted Net Profit	-27.06	-19.73	-24.69	-44.53	-28.36	-28.88
Adjustment below Net Profit	-0.08	-0.03	0.32	-0.35	0.17	6.38
P & L Balance brought forward	-270.24	-250.49	-226.12	-181.24	-153.06	-111.86
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-297.26	-270.24	-250.49	-226.12	-181.24	-134.35
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-12.49	-9.15	-11.45	-20.65	-14.45	-16.04
Earnings Per Share(Adj)-Unit Curr	-12.49	-9.15	-11.45	-20.65	-14.45	-16.04
Book Value-Unit Curr	-67.83	-55.29	-46.13	-34.83	-23.91	-13.89
Book Value(Adj)-Unit Curr	-67.83	-55.29	-46.13	-34.83	-23.91	-13.89

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)